Therefore, α7 nAChR activation by specific agonists or by nicotine, an exogenous ligand, could potentially improve metabolic disorders such as obesity and diabetes. This evidence concerns the gene CHRNA7 and obesity due to melanocortin 4 receptor deficiency.